60 Degrees Pharmaceuticals, Inc. (SXTP)
NASDAQ: SXTP · Real-Time Price · USD
0.828
+0.003 (0.32%)
At close: Jan 17, 2025, 4:00 PM
0.785
-0.043 (-5.16%)
After-hours: Jan 17, 2025, 5:36 PM EST
SXTP Employees
60 Degrees Pharmaceuticals had 3 employees as of December 31, 2023. The number of employees increased by 1 or 50.00% compared to the previous year.
Employees
3
Change (1Y)
1
Growth (1Y)
50.00%
Revenue / Employee
$154,204
Profits / Employee
-$2,721,716
Market Cap
1.90M
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 3 | 1 | 50.00% |
Dec 31, 2022 | 2 | - | - |
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 440,000 |
Johnson & Johnson | 131,900 |
Thermo Fisher Scientific | 122,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 89,900 |
Novartis AG | 76,057 |
Merck & Co. | 72,000 |
Novo Nordisk | 64,319 |
SXTP News
- 12 days ago - 60 Degrees Pharmaceuticals Enrolls First Patient in Tafenoquine Expanded Access Clinical Study for Persistent (B. microti) Babesiosis - GlobeNewsWire
- 4 weeks ago - Sixty Degrees Pharmaceuticals and Tufts Medical Center Announce Patent License Agreement to Advance Development of Tafenoquine for Babesiosis Treatment and Prevention - GlobeNewsWire
- 5 weeks ago - 60 Degrees Pharmaceuticals Expands Tafenoquine Clinical Trial for Babesiosis to Brigham and Women's Hospital - GlobeNewsWire
- 7 weeks ago - VSee Health and 60 Degrees Pharmaceuticals Interviews Aired on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV - Accesswire
- 2 months ago - 60 Degrees Pharmaceuticals and Can-Fite BioPharma Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV - Accesswire
- 2 months ago - 60 Degrees Pharmaceuticals Announces Third Quarter 2024 Results - GlobeNewsWire
- 3 months ago - 60 Degrees Pharmaceuticals Inc. Announces ARAKODA® Promotional Pilot in Advance of Expanded U.S. Launch - GlobeNewsWire
- 4 months ago - Hyliion Holdings And 2 Other Stocks Under $5 Executives Are Buying - Benzinga